Dyne Therapeutics
227 hedge funds and large institutions have $3.4B invested in Dyne Therapeutics in 2026 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 100 increasing their positions, 59 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
10.74% less ownership
Funds ownership: 124.57% → 113.83% (-11%)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
83% less call options, than puts
Call options by funds: $769K | Put options by funds: $4.47M
Holders
227
Holding in Top 10
5
Calls
$769K
Puts
$4.47M
Top Buyers
| 1 | +$228M | |
| 2 | +$66.9M | |
| 3 | +$40.3M | |
| 4 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
+$33.8M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$23.8M |
Top Sellers
| 1 | -$71.9M | |
| 2 | -$22M | |
| 3 | -$20.7M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$18.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$16.7M |
